Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasis
about
Fungicidal activity of fluconazole against Candida albicans in a synthetic vagina-simulative mediumOral lactoferrin treatment of experimental oral candidiasis in miceDosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patientsPossible inhibitory molecular mechanism of farnesol on the development of fluconazole resistance in Candida albicans biofilm.Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases.Activity of potent and selective host defense peptide mimetics in mouse models of oral candidiasisIn vitro susceptibility of the yeast pathogen cryptococcus to fluconazole and other azoles varies with molecular genotype.In vivo pharmacodynamics of antifungal drugs in treatment of candidiasis.Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.Oral Candida infection and colonization in solid organ transplant recipientsEfficacy of PLD-118, a novel inhibitor of candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant C. albicans.New model of oropharyngeal candidiasis in miceEfficacy of CS-758, a novel triazole, against experimental fluconazole-resistant oropharyngeal candidiasis in mice.Fluconazole Resistance among Oral Candida Isolates from People Living with HIV/AIDS in a Nigerian Tertiary Hospital.
P2860
Q24630977-35532019-AC51-4A6B-A0E4-20C6944A83FAQ24680333-542D6E71-3C6B-4B85-85B6-20F9B20020CCQ33981387-10A59D2A-7BC6-4B93-B1C9-A8052B812DEDQ33983022-8333287D-910B-46E2-A5E0-1614AFE1092DQ34079974-4627484C-0CE0-48D9-BFA2-9AD824EB6C68Q34105475-634C54D6-AC68-4846-AFC3-307E22DF9B93Q34416327-FBFF9B16-C5F3-4BF6-882A-84ED7AD20A5AQ34489508-40444862-FD0D-4DAD-93CE-C873F0F6AF23Q35091285-A40CB30F-711E-437D-B0C8-A90BE268C9C4Q35920633-60C94219-F16D-4032-997A-44B68F886471Q37235612-CBF78DE1-6A66-4ECB-B019-3D4D8F7724D2Q37568979-BF63ABC0-8882-4FF1-BB40-488B49D7EFFFQ39478875-14298336-5231-4043-A019-730E76DAB8F3Q39740568-BB13F8A9-3D37-4107-984B-372E37663820Q47646968-13122CF7-34B0-4924-A843-C732B03C2B48
P2860
Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasis
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Correlation between in vitro a ...... eal and esophageal candidiasis
@ast
Correlation between in vitro a ...... eal and esophageal candidiasis
@en
type
label
Correlation between in vitro a ...... eal and esophageal candidiasis
@ast
Correlation between in vitro a ...... eal and esophageal candidiasis
@en
prefLabel
Correlation between in vitro a ...... eal and esophageal candidiasis
@ast
Correlation between in vitro a ...... eal and esophageal candidiasis
@en
P2093
P2860
P1476
Correlation between in vitro a ...... eal and esophageal candidiasis
@en
P2093
C E Gonzalez
J D Bacher
S Piscitelli
P2860
P304
P407
P577
2000-06-01T00:00:00Z